Gurgaon Samachar

(Albany, USA) DelveInsight’s “Apheresis Market Insights, Competitive Landscape, and Market Forecast-2028” report delivers an in-depth understanding of Apheresis, historical and forecasted epidemiology as well as the Apheresis market trends in the North America, Europe, Asia-Pacific, and Rest of the World.

The Apheresis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Apheresis market size from 2020 to 2028, segmented by geographies (North America, Europe, Asia-Pacific, and Rest of the World). The Report also covers current Apheresis treatment machines, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Apheresis market.

 

Request for a Free Sample Report @ Apheresis Market Forecast

 

Some facts of the Apheresis Market Report are:

• The global apheresis market was valued at USD 2,230.66 million in 2021 and is estimated to grow at a CAGR of 8.75% during the forecast period (2023–2028) to reach USD 3,671.55 million by 2028.
• Leading Apheresis companies working in the market are Fresenius Kabi, Kidde-Fenwal Inc., Haemonetics Corporation, Isto Biologics, Asahi Kasei Medical Co. Ltd., Terumo Bct, Otsuka Holdings Co., Ltd., Bioelettronica Srl, Hemacare, Toray Industries, Inc, Mallinckrodt, Kaneka Corporation, B. Braun Melsungen Ag, Cerus Corporation, Kawasumi Laboratories Inc., Nikkiso Co., Ltd., Grifols, S.A. , Medica S.P.A. And Others.
• As per the National Cancer Institute 2022 (NCI), it has been estimated that there will be around 60,650 new cases of leukemia in the United States in 2022.
• Apheresis market is categorized based on the type of products (apheresis machine and disposable), the technology used (centrifugation and membrane filtration), the procedures performed (leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis, and others), the applications served (renal disorders, hematological disorders, neurological disorders, autoimmune disorders, and others), and the geographical regions.

 

Apheresis Overview

Apheresis is a medical procedure that involves removing blood from a patient and separating it into its components using a specialized machine. The desired component, such as plasma, platelets, or white blood cells, is extracted, while the rest of the blood is returned to the patient’s body. Apheresis is used to treat various conditions, including autoimmune disorders, certain cancers, and organ transplantation. It can also be used to collect specific blood components for donation. This procedure helps in managing and manipulating the patient’s blood composition, providing targeted treatment and improving overall health outcomes.

 

Learn more about Apheresis procedures in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/apheresis-market

 

Apheresis Market

The Apheresis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Apheresis market trends by analyzing the impact of current Apheresis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Apheresis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Apheresis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

Apheresis Recent updates:

• In June 2022, Terumo, a medical technology company, announces that the UK’s NHS England has selected the Spectra Optia® Apheresis System through the NHS MedTech Funding Mandate to treat sickle cell disease. As a result, Spectra Optia will be deployed more widely in hospitals across England.

• July 2022: Terumo Blood and Cell Technologies, a medical technology company, and and Eliaz Therapeutics Inc., a medical device company, announced an exclusive collaboration to assist with fighting sepsis-induced acute kidney injury and Acute kidney injury by aiming on removal of an upstream inflammatory protein known as Galectin-3 from blood plasma.

• July 2022: Fresenius Kabi introduced Thiotepa for Injection, USP, in the United Sates. Thiotepa is a generic equivalent of Tepadina®, is the latest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry. This injection is available immediately in solo-dose vials. It has several indications, which includes patients’ treatment with adenocarcinoma of the ovary or breast.

 

Explore more about latest Apheresis news and updates @ https://www.delveinsight.com/sample-request/apheresis-market

 

Apheresis Drugs Uptake

This section focuses on the uptake rate of the potential Apheresis drugs recently launched in the Apheresis market or expected to be launched in 2019-2032. The analysis covers the Apheresis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Apheresis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Apheresis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Apheresis Pipeline Development Activities

The Apheresis report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Apheresis key players involved in developing targeted therapeutics.

 

Request for a sample report to understand more about the Apheresis machines and disposables @ https://www.delveinsight.com/sample-request/apheresis-market

 

Apheresis Therapeutics Assessment

Major key companies are working proactively in the Apheresis market to develop novel therapies which will drive the Apheresis treatment markets in the upcoming years are Fresenius Kabi, Kidde-Fenwal Inc., Haemonetics Corporation, Isto Biologics, Asahi Kasei Medical Co. Ltd., Terumo Bct, Otsuka Holdings Co., Ltd., Bioelettronica Srl, Hemacare, Toray Industries, Inc, Mallinckrodt, Kaneka Corporation, B. Braun Melsungen Ag, Cerus Corporation, Kawasumi Laboratories Inc., Nikkiso Co., Ltd., Grifols, S.A. , Medica S.P.A. And Others.

 

Learn more about the emerging Apheresis companies and machines @ https://www.delveinsight.com/sample-request/apheresis-market

 

Apheresis Report Key Insights

1. Apheresis Patient Population

2. Apheresis Market Size and Trends

3. Key Cross Competition in the Apheresis Market

4. Apheresis Market Dynamics (Key Drivers and Barriers)

5. Apheresis Market Opportunities

6. Apheresis Therapeutic Approaches

7. Apheresis Pipeline Analysis

8. Apheresis Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Apheresis Market

 

Table of Contents

1. Apheresis Market Report Introduction

2. Apheresis Market Executive Summary

3. Apheresis Regulatory Analysis

4. Apheresis Market Key Factors Analysis

5. Apheresis Market Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on Apheresis Market

7. Apheresis Market Layout

8. Apheresis Market Global Company Share Analysis – Key 3-5 Companies

9. Apheresis Market Company and Product Profiles

10. Apheresis KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/apheresis-market